Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibodies to watch in 2023
Hélène Kaplon, Silvia Crescioli, Alicia M. Chenoweth, et al.
mAbs (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 212

Showing 1-25 of 212 citing articles:

Antibody–drug conjugates come of age in oncology
Charles Dumontet, Janice M. Reichert, Peter D. Senter, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 8, pp. 641-661
Closed Access | Times Cited: 366
Flow Cytometry: The Next Revolution
J. Paul Robinson, Raluca Ostafe, Sharath Narayana Iyengar, et al.
Cells (2023) Vol. 12, Iss. 14, pp. 1875-1875
Open Access | Times Cited: 82
A comprehensive overview on antibody-drug conjugates: from the conceptualization to cancer therapy
Federico Riccardi, Michele Dal Bo, Paolo Macor, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 76
Strategies for overcoming protein and peptide instability in biodegradable drug delivery systems
Miusi Shi, Kevin J. McHugh
Advanced Drug Delivery Reviews (2023) Vol. 199, pp. 114904-114904
Open Access | Times Cited: 50
Impact of structural modifications of IgG antibodies on effector functions
Timon Damelang, Maximilian Brinkhaus, Thijs L. J. van Osch, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 36
Assessing antibody and nanobody nativeness for hit selection and humanization with AbNatiV
Aubin Ramon, Montader Ali, Misha Atkinson, et al.
Nature Machine Intelligence (2024) Vol. 6, Iss. 1, pp. 74-91
Open Access | Times Cited: 26
Biparatopic antibodies: therapeutic applications and prospects
David L. Niquille, Kyle M. Fitzgerald, Nimish Gera
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 24
With great power, comes great responsibility: the importance of broadly measuring Fc-mediated effector function early in the antibody development process
Silvia Crescioli, Shashidhar S. Jatiani, Leonard Moise
mAbs (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Therapeutic Monoclonal Antibodies against Cancer: Present and Future
Marisa Delgado, José A. García‐Sanz
Cells (2023) Vol. 12, Iss. 24, pp. 2837-2837
Open Access | Times Cited: 31
Fc-Engineered Therapeutic Antibodies: Recent Advances and Future Directions
Dalia T. Abdeldaim, Katharina Schindowski
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2402-2402
Open Access | Times Cited: 28
Relatlimab: a novel drug targeting immune checkpoint LAG-3 in melanoma therapy
Jingjing Su, Yiting Fu, Zitong Cui, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 13
The Role of Force Fields and Water Models in Protein Folding and Unfolding Dynamics
Anna-Lena M. Fischer, Anna Tichy, Janik Kokot, et al.
Journal of Chemical Theory and Computation (2024) Vol. 20, Iss. 5, pp. 2321-2333
Open Access | Times Cited: 13
Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria
Stian Foss, Siri Aastedatter Sakya, Leire Aguinagalde, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Datopotamab deruxtecan: A novel antibody drug conjugate for triple-negative breast cancer
Francesca Matilde Schipilliti, Denise Drittone, Federica Mazzuca, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28385-e28385
Open Access | Times Cited: 13
What is the role of microbial biotechnology and genetic engineering in medicine?
Fernando Santos‐Beneit
MicrobiologyOpen (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 13
Homogeneous multi-payload antibody–drug conjugates
Toby Journeaux, Gonçalo J. L. Bernardes
Nature Chemistry (2024) Vol. 16, Iss. 6, pp. 854-870
Closed Access | Times Cited: 13
Variable domain mutational analysis to probe the molecular mechanisms of high viscosity of an IgG 1 antibody
Jing Dai, Saeed Izadi, Jonathan Zarzar, et al.
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 12
Bridging the gap with multispecific immune cell engagers in cancer and infectious diseases
Camille Rolin, Jacques Zimmer, Carole Seguin‐Devaux
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 7, pp. 643-661
Open Access | Times Cited: 12
Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practice
Ling Zhou, Yunlong Lu, Wei Liu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Structure and function of therapeutic antibodies approved by the US FDA in 2023
William R. Strohl
Antibody Therapeutics (2024) Vol. 7, Iss. 2, pp. 132-156
Open Access | Times Cited: 9
Reducing target binding affinity improves the therapeutic index of anti-MET antibody-drug conjugate in tumor bearing animals
Amita Datta‐Mannan, Hiuwan Choi, Zhaoyan Jin, et al.
PLoS ONE (2024) Vol. 19, Iss. 4, pp. e0293703-e0293703
Open Access | Times Cited: 9
The Patent and Literature Antibody Database (PLAbDab): an evolving reference set of functionally diverse, literature-annotated antibody sequences and structures
Brennan Abanades, Tobias Hegelund Olsen, Matthew I. J. Raybould, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. D1, pp. D545-D551
Open Access | Times Cited: 22
Recent Insights into the Etiopathogenesis of Diabetic Retinopathy and Its Management
Arpon Biswas, Abhijit Deb Choudhury, Sristi Agrawal, et al.
Journal of Ocular Pharmacology and Therapeutics (2023) Vol. 40, Iss. 1, pp. 13-33
Closed Access | Times Cited: 19
A high throughput bispecific antibody discovery pipeline
Aude I. Ségaliny, Jayapriya Jayaraman, Xiaohong Chen, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 18
Optimizing particle morphology during antibody precipitation for enhanced tangential flow filtration performance
Mirko Minervini, Ali Behboudi, Jovana R. Marzella, et al.
Separation and Purification Technology (2024) Vol. 338, pp. 126574-126574
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top